56S1.F Sartorius Stedim Biotech SA

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
221.80 EUR
Close of Nov 12, 2026
150.40 227.20
Market cap
EUR 21.6B
P/E
66.6x
P/B
5.05x
ROE
8.4%
Dividend yield
0.31%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 56S1.F undervalued?

Graham number

The Graham number of Sartorius Stedim Biotech SA cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Sartorius Stedim Biotech SA fundamental analysis

No fundamental analysis for Sartorius Stedim Biotech SA yet.

Sartorius Stedim Biotech SA stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Sartorius Stedim Biotech SA

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides flui…

Full company profile